Nakamoto, Inc. (NAKA)
5.00
-0.79
(-13.64%)
USD |
NASDAQ |
Nov 13, 16:00
4.93
-0.07
(-1.40%)
After-Hours: 19:59
Nakamoto Net Income (Quarterly) : 85.81M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 85.81M |
| June 30, 2026 | -131.20M |
| March 31, 2026 | -238.78M |
| December 31, 2025 | 37.26M |
| September 30, 2025 | -82.23M |
| June 30, 2025 | 0.00 |
| March 31, 2025 | -1.038M |
| December 31, 2024 | -1.002M |
| September 30, 2024 | -1.014M |
| June 30, 2024 | -1.320M |
| Date | Value |
|---|---|
| March 31, 2024 | -0.2823M |
| December 31, 2023 | -0.3249M |
| September 30, 2023 | -0.5151M |
| June 30, 2023 | -0.5964M |
| March 31, 2023 | -0.181M |
| December 31, 2022 | -0.446M |
| September 30, 2022 | -2.123M |
| June 30, 2022 | -0.035M |
| March 31, 2022 | 0.0636M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Astrana Health, Inc. | 20.27M |
| Agilon Health, Inc. | 34.91M |
| Starling Oncology, Inc. | -13.29M |
| American Oncology Network, Inc. | -- |
| Biodesix, Inc. | -8.032M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | -1.929M |
| Total Expenses (Quarterly) | -87.74M |
| EPS Diluted (Quarterly) | 4.068 |
| Enterprise Value | 237.18M |
| Profit Margin (Quarterly) | -4.45K% |
| Earnings Yield | -293.5% |
| Normalized Earnings Yield | -123.00 |